One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Glucose Monitoring Global Market

グルコースモニタリング市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2028年


[ 英語タイトル ] Glucose Monitoring Global Market - Forecast to 2027


Product Code : IQ4IHC00114189
Survey : IQ4I
Publish On : July, 2021
Number of Pages : 398
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6750 / Question Form
Enterprise User USD9000 / Question Form
ABBOTT LABORATORIES
ARKRAY, INC.
B BRAUN MELSUNGEN
DEXCOM INC.
I-SENS, INC.
LIFESCAN
MEDTRONIC, PLC
PHC HOLDINGS (ASCENSIA DIABETES CARE)
ROCHE HOLDINGS AG
SINOCARE
LIST OF COMPANIES MENTIONED IN THE REPORT
77 ELEKTRONIKA KFT
A&T CORPORATION
ABBOTT LABORATORIES
ACON DIABETES CARE INTERNATIONAL
ADALTIS S.R.L
AGAMATRIX, INC.
ALLIANCE INTERNATIONAL CO. LTD
ALLMEDICUS CO., LTD
AMBROSIA SYSTEMS, INC
ANDON HEALTH CO., LTD.
APEX BIOTECHNOLOGY CORP.
ARKRAY, INC.
B. BRAUN MELSUNGEN AG
BEATO CURV
BECTON DICKINSON AND COMPANY
BEIJING YICHENG BIOELECTRONICS TECHNOLOGY CO., LTD.
BEURER GMBH
BIOCHEMICAL SYSTEMS INTERNATIONAL S.P.A.
BIOLAND TECHNOLOGY LTD.
BIONIME CORPORATION
BIOPTIK LTD.
BIO-RAD LABORATORIES, INC
BIOTEST MEDICAL CORPORATION
BREMED LIMITED
CAMBRIDGE SENSORS LTD (MICRODOT)
CHUNGDO PHARM. CO., LTD
CONTEC MEDICAL SYSTEMS CO., LTD.
CONVERGENT TECHNOLOGIES GMBH & CO. KG
CTK BIOTECH, INC
DANAHER CORPORATION(HEMOCUE)
DARIO HEALTH CORP.
DELBIO, INC.
DEXCOM, INC
DIABETOMICS, INC
DIAMONTECH AG
DR. MOREPEN
EKF DIAGNOSTICS
EPS BIO TECHNOLOGY CORP.
EVIA MEDICAL TECHNOLOGIES
FIA BIOMED GMBH
FORA CARE, INC
GENERAL LIFE BIOTECHNOLOGY CO., LTD.
GENESIS HEALTH TECHNOLOGIES, INC.
GLUCORX
GLUCOSTRATUS LTD
GLYSENS INCORPORATED
HAIDEN TECHNOLOGY PVT. LTD
HANGZHOU SEJOY ELECTRONICS & INSTRUMENTS CO., LTD.
HMD BIOMEDICAL
HUBDIC CO LTD
IHEALTH LABS, INC.
IME-DC GMBH
IN4 TECHNOLOGY CORPORATION
INTEGRITY APPLICATIONS
INTUITY MEDICAL, INC.
I-SENS
IXENSOR COMPANY LTD.
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD (YUWELL)
K-JUMP HEALTH CO., LTD.
LIFOTRONIC TECHNOLOGY CO., LTD
LOBECK MEDICAL AG
L-TAC MEDICARE PTE LTD.
MEDISANA, GMBH
MEDIWISE (V.S. INTERNATIONAL)
MEDSOURCE OZONE BIOMEDICALS PVT. LTD.
MEDTRONIC, PLC
MEDTRUM TECHNOLOGIES, INC
MENARINI GROUP (A. MENARINI DIAGNOSTICS S.R.L)
MICO BIOMED CO., LTD.
MICROTECH MEDICAL, INC. (AIDEX, LTD)
NATIONAL DIAGNOSTIC PRODUCTS PTY LTD
NEMAURA MEDICAL,INC.
NIPRO CORPORATION
NOVA BIOMEDICAL
NOVIOSENSE BV
OK BIOTECH CO., LTD
OMRON HEALTHCARE
OSANG HEALTH CARE CO LTD
PALMDOC, LTD
PEPEX BIOMEDICAL
PHARMA TECH SOLUTIONS, INC.
PHC HOLDINGS (ASCENSIA DIABETES CARE HOLDINGS AG)
PHILIPS (BIOTELEMETRY, INC)
PHILOSYS CO., LTD.
PKVITALITY
PLATINUM EQUITY (LIFE SCAN, INC.)
PRODIGY DIABETES CARE, LLC
PULSATOM HEALTHCARE PRIVATE LIMITED
ROCHE DIAGNOSTICS
ROMED HOLLAND (VAN OOSTVEEN MEDICAL B.V.)
SANOFI
SD BIOSENSOR, INC.
SENSEONICS, INC.
SHENZHEN ESER INDUSTRIAL DESIGN LTD. CO.
SINOCARE
TAIDOC TECHNOLOGY CORPORATION
TERUMO
THERMO FISHER SCIENTIFIC
TIANJIN EMPECS MEDICAL DEVICE CO., LTD.
TRINITY BIOTECH, PLC
TRULY INSTRUMENT LIMITED
TYSON BIORESEARCH INC
VISGENEER INC
VITREX MEDICAL A/S
VIVACHEK LABORATORIES, INC.
WOCKHARDT LIMITED
YPSOMED AG

[Report Description]

Glucose Monitoring consists of products that are essential for measuring glucose levels in diabetes patients. With the projected rise in the aged population and awareness about diabetes conditions, the market is focused on growing with newer technology and improved products. According to IQ4I analysis, the Glucose Monitoring global market is expected to grow at a low single digit CAGR from 2020 to 2027 reach $15,321.8 million by 2027.
Factors driving the Glucose Monitoring market are the global rise in the prevalence and incidence of diabetes, increasing demand for a less minimally invasive or non-invasive and point-of-care device; increasing R&D investments are driving the market growth, whereas, the growing diffusion of smart devices and digital platforms increasing compliance and management of diabetes is creating opportunities in the coming years. The high cost of the products, frequent product recalls and inadequate reimbursement is restraining the market growth. The stringent regulations, privacy concerns and safety issues are threats for the market growth.
Glucose Monitoring global market is classified based on products, sample type, end-users and geography. The product segment is divided into three segments i.e., Invasive, Non-Invasive and lab-based glucose monitoring products. The Invasive glucose monitoring products segment accounted for the largest share in 2020 due to technological advancements, easy use, and patient-friendly nature of products. Invasive products are further divided into Self-monitoring blood glucose (SMBG) and continuous glucose monitoring (CGM) products. The self glucose monitoring segment accounted for the largest share in 2020 due to their relatively lower cost. The Self glucose monitoring products are further classified into blood glucose monitors, blood glucose test strips, lancets and others. The blood glucose testing strips segment accounted for the largest share in 2020 due development of no coding strips. The continuous glucose monitoring market includes sensors/receivers and transmitters. The continuous glucose market includes products sensors/receivers and transmitters. The continuous glucose segment is the fastest-growing segment and is projected to grow at a high single digit CAGR from 2020 to 2027.
Based on sample type the market is segmented into blood, urine and others. The blood segment accounted for the largest share in 2020 and is projected to grow at a low single CAGR from 2020 to 2027 due to the accuracy of results. Other source-based glucose monitoring segment is the fastest-growing segment and is projected to grow at a double digit CAGR from 2020 to 2027 due to increased R&D investment, many products are CE approved and expected to launch very soon in the market.
Based on end-users the market is segmented into hospitals, private clinics, home care and ambulatory settings. Among end-users, the home care segment accounted for the largest share in 2020 and is projected to grow at low single digit CAGR from 2020 to 2027 due to the availability of over the counter (OTC) self blood glucose monitor and ease in operating these monitors and thereby reducing the frequent visits to hospitals or clinics for checking glucose levels.
Based on geography the market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, Italy and Rest of E.U.), Asia-Pacific (Japan, China, India and Rest of APAC) and the Rest of the World (Brazil, Middle East & others and Rest of Latin America). North America accounts for the highest market share in 2020 followed by Europe. The steep rise in the aging population, advancement in technology, awareness of people about treatment options and favorable government policies are driving factors of the glucose monitoring market. However, Asian countries especially India and China are the fastest-growing regions with their growing demand for glucose monitoring products.
Major players in the Glucose monitoring market include Abbott Laboratories (U.S.), Dexcom (U.S.), Roche (Switzerland), LifeScan (U.S.), Medtronic, Inc. (Ireland), PHC Holding (Ascensia) (Japan), Arkray (Japan), Sinocare (China), B. Braun Melsungen AG (Germany), and i-Sens, Inc., (South Korea), etc.
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Rest of N.A.
• Europe
o Germany
o Italy
o France
o Rest of E.U.
• Asia-Pacific
o Japan
o China
o India
o Rest of APAC
• Rest of the World (RoW)
o Brazil
o Rest of Latin America
o The Middle East & Others


1 EXECUTIVE SUMMARY 22
2 INTRODUCTION 28
2.1 KEY TAKEAWAYS 28
2.2 REPORT DESCRIPTION 29
2.3 MARKETS COVERED 31
2.4 STAKEHOLDERS 32
2.5 RESEARCH METHODOLOGY 33
2.5.1 MARKET SIZE ESTIMATION 35
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 37
2.5.3 SECONDARY SOURCES 38
2.5.4 PRIMARY SOURCES 38
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 39
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 40
2.5.7 ASSUMPTIONS 41
3 MARKET ANALYSIS 44
3.1 INTRODUCTION 44
3.2 MARKET SEGMENTATION 44
3.3 FACTORS INFLUENCING MARKET 46
3.3.1 DRIVERS AND OPPORTUNITIES 46
3.3.1.1 The global rise in the prevalence and incidence of diabetes 46
3.3.1.2 Increasing demand for minimally or non-invasive and point-of-care devices. 48
3.3.1.3 Increasing R & D investments 48
3.3.1.4 Growing diffusion of smart devices and digital platforms increasing compliance
and management of diabetes 49
3.3.2 RESTRAINTS AND THREATS 50
3.3.2.1 High cost associated with the products 50
3.3.2.2 Inadequate reimbursement 51
3.3.2.3 Product recalls 52
3.3.2.4 Strict regulation of glucose monitoring devices by regulatory organizations like
the FDA and others 53
3.3.2.5 Privacy concern and safety issues in connected devices 54
3.4 REGULATORY AFFAIRS 55
3.4.1 U.S. 55
3.4.2 EUROPE 59
3.4.3 CHINA 61
3.4.4 INDIA 62
3.4.5 JAPAN 65
3.5 REIMBURSEMENT SCENARIO 65
3.6 PATENT ANALYSIS 72
3.7 TECHNOLOGY ADVANCEMENTS 74
3.7.1 WIRELESS SMART CONTACT LENS 74
3.7.2 SALIVA BASED BIOSENSORS 74
3.7.3 RF (RADIOFREQENCY) SENSOR FOR CGM 75
3.8 PRODUCT LAUNCHES AND APPROVALS 75
3.9 FUNDING SCENARIO 77
3.10 PORTER’S FIVE FORCE ANALYSIS 83
3.10.1 THREAT OF NEW ENTRANTS 84
3.10.2 THREAT OF SUBSTITUTES 85
3.10.3 BARGAINING POWER OF SUPPLIERS 86
3.10.4 BARGAINING POWER OF BUYERS 86
3.10.5 RIVALRY AMONG EXISTING COMPETITORS 87
3.11 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 88
3.11.1 GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS 88
3.11.2 SELF BLOOD GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS 91
3.11.3 CONTINUOUS GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS 94
3.12 REGIONAL MARKET SHARE ANALYSIS 96
3.12.1 NORTH AMERICA SELF MONITORING OF BLOOD GLUCOSE MARKET SHARE ANALSIS 96
3.12.2 EUROPE SELF GLUCOSE MONITORING MARKET SHARE ANALYSIS 98
3.12.3 ASIA-PACIFIC SELF GLUCOSE MONITORING MARKET SHARE ANALYSIS 100
3.12.4 ROW SELF GLUCOSE MONITORING MARKET SHARE ANALYSIS 103
3.12.5 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING MARKET SHARE ANALYSIS 105
3.12.6 EUROPE CONTINUOUS GLUCOSE MONITORING MARKET SHARE ANALYSIS 107
3.12.7 ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING MARKET SHARE ANALYSIS 109
3.12.8 ROW CONTINUOUS GLUCOSE MONITORING MARKET SHARE ANALYSIS 111
3.13 UNITS SOLD 113
3.13.1 GLUCOSE TESTING STRIPS UNITS SOLD 113
3.13.2 NUMBER OF CGM SENSORS SOLD 115
3.14 MARKET PENETRATION ANALYSIS 117
3.15 COVID-19 IMPACT 120
3.15.1 COVID-19 IMPACT ON GLUCOSE MONITORING MARKET 120
3.15.2 COVID IMPACT ON ELECTIVE SURGICAL PROCEDURES 121
3.15.3 COVID IMPACT ON SUPPLY CHAIN 121
3.15.4 COVID IMPACT ON CONSUMERS 122
4 GLUCOSE MONITORING GLOBAL MARKET, BY PRODUCTS 123
4.1 INTRODUCTION 123
4.2 INVASIVE GLUCOSE MONITORING 125
4.2.1 SELF GLUCOSE MONITORING 128
4.2.1.1 Blood glucose meter 131
4.2.1.2 Blood glucose testing strips 133
4.2.1.3 Lancets 136
4.2.1.4 Others 138
4.2.2 CONTINUOUS GLUCOSE MONITORING 139
4.2.2.1 Glucose sensors 143
4.2.2.2 Transmitters and receivers 144
4.3 NON-INVASIVE GLUCOSE MONITORING 145
4.4 LAB BASED GLUCOSE MONITORING 149
5 GLUCOSE MONITORING GLOBAL MARKET, BY SAMPLE SOURCE 154
5.1 INTRODUCTION 154
5.2 BLOOD-BASED GLUCOSE MONITORING 157
5.3 URINE BASED GLUCOSE MONITORING 159
5.4 OTHER SOURCES BASED GLUCOSE MONITORING 162
6 GLUCOSE MONITORING GLOBAL MARKET, BY END-USERS 166
6.1 INTRODUCTION 166
6.2 HOSPITALS 169
6.3 HOME CARE 172
6.4 PRIVATE CLINICS 175
6.5 AMBULATORY SETTINGS 176
7 REGIONAL ANALYSIS 178
7.1 INTRODUCTION 178
7.2 NORTH AMERICA 181
7.2.1 U.S. 198
7.2.2 REST OF NORTH AMERICA 205
7.3 EUROPE 212
7.3.1 GERMANY 229
7.3.2 ITALY 235
7.3.3 FRANCE 241
7.3.4 REST OF EUROPE 248
7.4 ASIA - PACIFIC 255
7.4.1 JAPAN 271
7.4.2 CHINA 277
7.4.3 INDIA 283
7.4.4 REST OF ASIA-PACIFIC 290
7.5 REST OF THE WORLD 296
7.5.1 BRAZIL 312
7.5.2 MIDDLE EAST & OTHERS 318
7.5.3 REST OF LATIN AMERICA 324
8 COMPETITIVE LANDSCAPE 331
8.1 INTRODUCTION 331
8.2 APPROVAL 332
8.3 AGREEMENTS, COLLABORATION & PARTNERSHIPS 334
8.4 NEW PRODUCT LAUNCH 336
8.5 ACQUISITION 338
8.6 FUNDING 339
8.7 OTHER DEVELOPMENTS 340
9 MAJOR COMPANIES 342
9.1 ABBOTT LABORATORIES, INC 342
9.1.1 OVERVIEW 342
9.1.2 FINANCIALS 343
9.1.3 PRODUCT PORTFOLIO 347
9.1.4 KEY DEVELOPMENTS 347
9.1.5 BUSINESS STRATEGY 349
9.1.6 SWOT ANALYSIS 350
9.2 ARKRAY, INC. 351
9.2.1 OVERVIEW 351
9.2.2 FINANCIALS 351
9.2.3 PRODUCT PORTFOLIO 352
9.2.4 KEY DEVELOPMENTS 353
9.2.5 BUSINESS STRATEGY 353
9.2.6 SWOT ANALYSIS 354
9.3 B.BRAUN MELSUNGEN AG 355
9.3.1 OVERVIEW 355
9.3.2 FINANCIALS 356
9.3.3 PRODUCT PORTFOLIO 358
9.3.4 KEY DEVELOPMENTS 359
9.3.5 BUSINESS STRATEGY 359
9.3.6 SWOT ANALYSIS 360
9.4 DEXCOM, INC. 361
9.4.1 OVERVIEW 361
9.4.2 FINANCIALS 362
9.4.3 PRODUCT PORTFOLIO 363
9.4.4 KEY DEVELOPMENTS 364
9.4.5 BUSINESS STRATEGY 365
9.4.6 SWOT ANALYSIS 366
9.5 I-SENS, INC. 367
9.5.1 OVERVIEW 367
9.5.2 FINANCIALS 368
9.5.3 PRODUCT PORTFOLIO 369
9.5.4 KEY DEVELOPMENTS 369
9.5.5 BUSINESS STRATEGY 370
9.5.6 SWOT ANALYSIS 370
9.6 LIFESCAN 371
9.6.1 OVERVIEW 371
9.6.2 FINANCIALS 371
9.6.3 PRODUCT PORTFOLIO 371
9.6.4 KEY DEVELOPMENTS 372
9.6.5 BUSINESS STRATEGY 373
9.6.6 SWOT ANALYSIS 374
9.7 MEDTRONIC, PLC 375
9.7.1 OVERVIEW 375
9.7.2 FINANCIALS 376
9.7.3 PRODUCT PORTFOLIO 378
9.7.4 KEY DEVELOPMENTS 379
9.7.5 BUSINESS STRATEGY 380
9.7.6 SWOT ANALYSIS 381
9.8 PHC HOLDINGS (ASCENCIA DIABETES) 382
9.8.1 OVERVIEW 382
9.8.2 FINANCIALS 382
9.8.3 PRODUCT PORTFOLIO 383
9.8.4 KEY DEVELOPMENTS 383
9.8.5 BUSINESS STRATEGY 384
9.8.6 SWOT ANALYSIS 385
9.9 ROCHE HOLDINGS AG 386
9.9.1 OVERVIEW 386
9.9.2 FINANCIALS 387
9.9.3 PRODUCT PORTFOLIO 391
9.9.4 KEY DEVELOPMENTS 392
9.9.5 BUSINESS STRATEGY 392
9.9.6 SWOT ANALYSIS 393
9.10 SINOCARE INC. 394
9.10.1 OVERVIEW 394
9.10.2 FINANCIALS 395
9.10.3 PRODUCT PORTFOLIO 396
9.10.4 KEY DEVELOPMENTS 396
9.10.5 BUSINESS STRATEGY 396
9.10.6 SWOT ANALYSIS 397

LIST OF FIGURES
FIGURE 1 GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY REGION
(2019-2027) ($MN) 27
FIGURE 2 RESEARCH METHODOLOGY: GLUCOSE MONITORING GLOBAL MARKET 34
FIGURE 3 GLUCOSE MONITORING GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 35
FIGURE 4 GLUCOSE MONITORING GLOBAL MARKET: FORECASTING MODEL 36
FIGURE 5 GLUCOSE MONITORING GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION 37
FIGURE 6 GLUCOSE MONITORING GLOBAL MARKET SEGMENTATION 45
FIGURE 7 MARKET DYNAMICS 46
FIGURE 8 GLUCOSE MONITORING GLOBAL MARKET: PATENT FILING, BY MAJOR PLAYERS (2016-2021) 73
FIGURE 9 GLUCOSE MONITORING MARKET: PORTER’S ANALYSIS 84
FIGURE 10 GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS,
BY KEY PLAYERS, 2020 88
FIGURE 11 SELF BLOOD GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 91
FIGURE 12 CONTINUOUS GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 94
FIGURE 13 NORTH AMERICA SELF MONITORING OF BLOOD GLUCOSE MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 96
FIGURE 14 EUROPE SELF GLUCOSE MONITORING MARKET SHARE ANALYSIS,
BY KEY PLAYERS, 2020 98
FIGURE 15 ASIA-PACIFIC SELF GLUCOSE MONITORING MARKET SHARE ANALYSIS,
BY KEY PLAYERS, 2020 100
FIGURE 16 ROW SELF GLUCOSE MONITORING MARKET SHARE ANALYSIS,
BY KEY PLAYERS, 2020 103
FIGURE 17 NORTH AMERICA CONTINOUS GLUCOSE MONITORING MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 105
FIGURE 18 EUROPE CONTINUOUS GLUCOSE MONITORING MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 107
FIGURE 19 ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 109
FIGURE 20 ROW CONTINUOUS GLUCOSE MONITORING MARKET SHARE ANALYSIS,
BY KEY PLAYERS, 2020 111
FIGURE 21 SELF MONITORING GLUCOSE TEST STRIPS GLOBAL UNITS SOLD,
BY REGION AND COUNTRYWISE (2020) (MN) 114
FIGURE 22 CGM SENSORS GLOBAL UNITS SOLD, BY REGION AND COUNTRYWISE (2020) (MN) 116
FIGURE 23 GLOBAL SMBG DEVICES PENETRATION, (2020) 118
FIGURE 24 GLOBAL CGM DEVICES PENETRATION, (2020) 119
FIGURE 25 GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY PRODUCTS (2020) ($MN) 128
FIGURE 26 CONTINUOUS GLUCOSE MONITORING GLOBAL MARKET SHARE,
BY PRODUCTS (2020 V/S 2027) (%) 142
FIGURE 27 NON-INVASIVE GLUCOSE MONITORS GLOBAL MARKET SHARE,
BY REGION (2020 V/S 2027) (%) 149
FIGURE 28 LAB BASED GLUCOSE MONITORING GLOBAL MARKET SHARE,
BY REGION (2020 V/S 2027) (%) 153
FIGURE 29 GLUCOSE MONITORING GLOBAL MARKET SHARE, BY SAMPLE SOURCE (2020 V/S 2027) (%) 156
FIGURE 30 URINE BASED GLUCOSE MONITORING GLOBAL MARKET SHARE,
BY REGION (2020 V/S 2027) (%) 161
FIGURE 31 OTHER SOURCES BASED GLUCOSE MONITORING GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%) 165
FIGURE 32 GLUCOSE MONITORING GLOBAL MARKET SHARE, BY END USER
(2020 V/S 2027) (%) 168
FIGURE 33 HOME CARE GLUCOSE MONITORING GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%) 174
FIGURE 34 GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY REGION
(2019-2027) ($MN) 180
FIGURE 35 NORTH AMERICA GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2020) ($MN) 185
FIGURE 36 NORTH AMERICA SELF BLOOD GLUCOSE MONITORING MARKET SHARE,
BY PRODUCTS (2020 V/S 2027) (%) 187
FIGURE 37 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING MARKET SHARE,
BY PRODUCTS (2020 V/S 2027) (%) 189
FIGURE 38 NORTH AMERICA GLUCOSE MONITORING MARKET SHARE, BY SAMPLE SOURCE (2020 V/S 2027) (%) 191
FIGURE 39 NORTH AMERICA GLUCOSE MONITORING MARKET SHARE, BY END-USER (2020 V/S 2027) (%) 193
FIGURE 40 NORTH AMERICA GLUCOSE MONITORING MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%) 195
FIGURE 41 NORTH AMERICA SMBG MARKET PENETRATION, (2020) 196
FIGURE 42 NORTH AMERICA CGM MARKET PENETRATION, (2020) 197
FIGURE 43 U.S. GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS, BY SAMPLE SOURCE & BY END-USER (2020 V/S 2027)($MN) 200
FIGURE 44 U.S. INVASIVE GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN) 202
FIGURE 45 U.S. SMBG MARKET PENETRATION, (2020) 203
FIGURE 46 U.S. CGM MARKET PENETRATION, (2020) 204
FIGURE 47 REST OF NORTH AMERICA GLUCOSE MONITORING MARKET REVENUE, BY PRODUCT, BY SAMPLE SOURCE, AND BY END-USER (2020 V/S 2027) ($MN) 207
FIGURE 48 REST OF N. A. INVASIVEGLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2020 V/S 2027) ($MN) 209
FIGURE 49 REST OF N.A. SMBG MARKET PENETRATION, (2020) 210
FIGURE 50 REST OF N.A. CGM MARKET PENETRATION, (2020) 211
FIGURE 51 EUROPE AND INVASIVE GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2020) ($MN) 216
FIGURE 52 EUROPE SELF BLOOD GLUCOSE MONITORING MARKET SHARE,
BY PRODUCTS (2020 V/S 2027) (%) 218
FIGURE 53 EUROPE CONTINUOUS GLUCOSE MONITORING MARKET SHARE,
BY PRODUCTS (2020 V/S 2027) (%) 220
FIGURE 54 EUROPE GLUCOSE MONITORING MARKET SHARE, BY SAMPLE SOURCE (2020 V/S 2027) (%) 222
FIGURE 55 EUROPE GLUCOSE MONITORING MARKET SHARE, BY END-USER
(2020 V/S 2027) (%) 224
FIGURE 56 EUROPE GLUCOSE MONITORING MARKET SHARE, BY COUNTRY
(2020 V/S 2027) (%) 226
FIGURE 57 EUROPE SMBG MARKET PENETRATION, (2020) 227
FIGURE 58 EUROPE CGM MARKET PENETRATION, (2020) 228
FIGURE 59 GERMANY GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
BY SAMPLE SOURCE & BY END-USER (2020 V/S 2027) ($MN) 231
FIGURE 60 GERMANY INVASIVE GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2020 V/S 2027) ($MN) 233
FIGURE 61 GERMANY SMBG MARKET PENETRATION, (2020) 234
FIGURE 62 GERMANY CGM MARKET PENETRATION, (2020) 235
FIGURE 63 ITALY GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
BY SAMPLE SOURCE & BY-END-USER (2020 V/S 2027) ($MN) 237
FIGURE 64 ITALY INVASIVE GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN) 239
FIGURE 65 ITALY SMBG MARKET PENETRATION, (2020) 240
FIGURE 66 ITALY CGM MARKET PENETRATION, (2020) 241
FIGURE 67 FRANCE GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
BY SAMPLE SOURCE, AND BY END-USER (2020 V/S 2027) ($MN) 243
FIGURE 68 FRANCE INVASIVE GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2020 V/S 2027) ($MN) 245
FIGURE 69 FRANCE SMBG MARKET PENETRATION (2020) 246
FIGURE 70 FRANCE CGM MARKET PENETRATION (2020) 247
FIGURE 71 REST OF EUROPE GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS, BY SAMPLE SOURCE, AND BY END-USER (2020 V/S 2027) ($MN) 250
FIGURE 72 REST OF E.U. INVASIVE GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2020 V/S 2027) ($MN) 252
FIGURE 73 REST OF EUROPE SMBG MARKET PENETRATION (2020) 253
FIGURE 74 REST OF EUROPE CGM MARKET PENETRATION (2020) 254
FIGURE 75 ASIA-PACIFIC & INVASIVE GLUCOSE MONITORING DEVICES MARKET REVENUE, BY PRODUCTS (2020) ($MN) 259
FIGURE 76 ASIA-PACIFIC SELF BLOOD GLUCOSE MONITORING MARKET SHARE,
BY PRODUCTS (2020 V/S 2027) (%) 261
FIGURE 77 ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING MARKET SHARE,
BY PRODUCTS (2020 V/S 2027) (%) 263
FIGURE 78 ASIA-PACIFIC GLUCOSE MONITORING MARKET REVENUE, BY SAMPLE SOURCE (2020 V/S 2027) ($MN) 265
FIGURE 79 ASIA-PACIFIC GLUCOSE MONITORING MARKET SHARE, BY END-USER (2020 V/S 2027) (%) 267
FIGURE 80 ASIA-PACIFIC GLUCOSE MONITORING MARKET SHARE, BY COUNTRY
(2020 V/S 2027) (%) 269
FIGURE 81 ASIA-PACIFIC SMBG MARKET PENETRATION (2020) 270
FIGURE 82 ASIA-PACIFIC CGM MARKET PENETRATION (2020) 271
FIGURE 83 JAPAN GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
BY SAMPLE SOURCE AND BY END-USER (2020 V/S 2027) ($MN) 273
FIGURE 84 JAPAN INVASIVE GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN) 275
FIGURE 85 JAPAN SMBG MARKET PENETRATION (2020) 276
FIGURE 86 JAPAN CGM MARKET PENETRATION (2020) 277
FIGURE 87 CHINA GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
BY SAMPLE SOURCE AND BY END-USER (2020 V/S 2027) ($MN) 279
FIGURE 88 CHINA INVASIVE GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2020 V/S 2027) ($MN) 281
FIGURE 89 0 CHINA SMBG MARKET PENETRATION (2020) 282
FIGURE 90 CHINA CGM MARKET PENETRATION (2020) 283
FIGURE 91 INDIA GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
BY SAMPLE SOURCE AND BY END-USER (2020 V/S 2027) ($MN) 285
FIGURE 92 INDIA INVASIVE GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN) 287
FIGURE 93 INDIA SMBG MARKET PENETRATION (2020) 288
FIGURE 94 INDIA CGM MARKET PENETRATION (2020) 289
FIGURE 95 REST OF APAC GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS, BY SAMPLE SOURCE AND BY END-USER (2020 V/S 2027) ($MN) 292
FIGURE 96 REST OF APAC INVASIVE GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2020 V/S 2027) ($MN) 294
FIGURE 97 REST OF APAC SMBG MARKET PENETRATION (2020) 295
FIGURE 98 REST OF APAC CGM MARKET PENETRATION (2020) 296
FIGURE 99 ROW & INVASIVE GLUCOSE MONITORING DEVICES MARKET REVENUE,
BY PRODUCTS (2020) ($MN) 300
FIGURE 100 ROW SELF BLOOD GLUCOSE MONITORING MARKET SHARE, BY PRODUCTS (2020 V/S 2027) (%) 302
FIGURE 101 ROW CONTINUOUS GLUCOSE MONITORING MARKET SHARE, BY PRODUCTS (2020 V/S 2027) (%) 304
FIGURE 102 ROW GLUCOSE MONITORING MARKET SHARE, BY SAMPLE SOURCE (2020 V/S 2027) (%) 306
FIGURE 103 ROW GLUCOSE MONITORING MARKET SHARE, BY END-USER
(2020 V/S 2027) (%) 308
FIGURE 104 ROW GLUCOSE MONITORING MARKET REVENUE, BY COUNTRY
(2020 V/S 2027) ($MN) 310
FIGURE 105 ROW SMBG MARKET PENETRATION (2020) 311
FIGURE 106 ROW CGM MARKET PENETRATION (2020) 312
FIGURE 107 BRAZIL GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
BY SAMPLE SOURCE AND BY END-USER (2020 V/S 2027) ($MN) 314
FIGURE 108 BRAZIL INVASIVE GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2020 V/S 2027) ($MN) 316
FIGURE 109 BRAZIL SMBG MARKET PENETRATION (2020) 317
FIGURE 110 BRAZIL CGM MARKET PENETRATION (2020) 318
FIGURE 111 MIDDLE EAST & OTHERS GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS, BY SAMPLE SOURCE AND BY END-USER (2020 V/S 2027) ($MN) 320
FIGURE 112 MIDDLE EAST & OTHERS INVASIVE GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN) 322
FIGURE 113 MIDDLE EAST & OTHERS SMBG MARKET PENETRATION (2020) 323
FIGURE 114 MIDDLE EAST & OTHERS CGM MARKET PENETRATION (2020) 324
FIGURE 115 REST OF LATIN AMERICA GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS, BY SAMPLE SOURCE AND BY END-USER (2020 V/S 2027) ($MN) 326
FIGURE 116 REST OF LATIN AMERICA INVASIVE GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN) 328
FIGURE 117 REST OF LATIN AMERICA SMBG MARKET PENETRATION (2020) 329
FIGURE 118 REST OF LATIN AMERICA CGM MARKET PENETRATION (2020) 330
FIGURE 119 KEY GROWTH STRATEGIES (2020–2021) 332
FIGURE 120 SWOT: ABBOTT LABORATORIES 350
FIGURE 121 SWOT: ARKRAY, INC 354
FIGURE 122 SWOT: B BRAUN MELSUNGEN 360
FIGURE 123 SWOT: DEXCOM INC. 366
FIGURE 124 SWOT: I-SENS, INC. 370
FIGURE 125 SWOT: LIFESCAN 374
FIGURE 126 SWOT: MEDTRONIC, PLC 381
FIGURE 127 SWOT: PHC HOLDINGS (ASCENSIA DIABETES CARE) 385
FIGURE 128 SWOT: ROCHE HOLDINGS AG 393
FIGURE 129 SWOT: SINOCARE 397

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+